Table 2 Age and stage for the 304 controls
From: Survival in Norwegian BRCA1 mutation carriers with breast cancer
no(%) | ||
|---|---|---|
Age | <30 | 11(3.6) |
30–39 | 81(26.6) | |
40–49 | 134(44.2 | |
50–59 | 56(18.4) | |
60–69 | 16(5.3) | |
>/= 70 | 6(2.0) | |
Stage | 1(T1-2N0) | 204(67.1) |
2(T1-2N1) | 91(29.9) | |
3(T1-2N2-3, T3-4N0-3) | 9(3.0) |